Literature DB >> 17823604

Prostate biopsy strategies.

Joseph C Presti1.   

Abstract

Early detection is critical to good management of prostate cancer patients. Markers for detection, such as prostate specific antigen (PSA), and prostate biopsy are paramount for establishing an efficient diagnosis. Patients having an initial biopsy should undergo an extended biopsy scheme incorporating at least 10-12 cores, while in those undergoing a repeat biopsy particular attention should be addressed to the anterior apex. Saturation biopsies should be considered for patients with several prior negative biopsies. The chance of finding cancer on repeat biopsies has diminished in patients harboring high-grade prostatic intraepithelial neoplasia but not in those with atypical small acinar proliferation. This article reviews the history of prostate biopsy strategies with particular attention paid towards the development of extended biopsy schemes. Furthermore, a strategy is recommended for initial and repeat biopsy patients.

Entities:  

Mesh:

Year:  2007        PMID: 17823604     DOI: 10.1038/ncpuro0887

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  17 in total

Review 1.  Strategies for repeat prostate biopsies.

Authors:  Martha K Terris
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

Review 2.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

3.  Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.

Authors:  Xingwang Jia; Jing Chen; Shisheng Sun; Weiming Yang; Shuang Yang; Punit Shah; Naseruddin Hoti; Bob Veltri; Hui Zhang
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

4.  Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.

Authors:  Michael Josef Mitterberger; Friedrich Aigner; Wolfgang Horninger; Hanno Ulmer; Silvio Cavuto; Ethan J Halpern; Ferdinand Frauscher
Journal:  Eur Radiol       Date:  2010-06-23       Impact factor: 5.315

5.  New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.

Authors:  Robert K Nam; William Zhang; Katherine Siminovitch; Adam Shlien; Michael W Kattan; Laurence H Klotz; John Trachtenberg; Yan Lu; Jinyi Zhang; Changhong Yu; Ants Toi; D Andrew Loblaw; Vasundara Venkateswaran; Aleksandra Stanimirovic; Linda Sugar; David Malkin; Arun Seth; Steven A Narod
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

6.  Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.

Authors:  Yan Li; Sheng-Ce Tao; G Steven Bova; Alvin Y Liu; Daniel W Chan; Heng Zhu; Hui Zhang
Journal:  Anal Chem       Date:  2011-10-26       Impact factor: 6.986

7.  Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer.

Authors:  Yuan Tian; G Steven Bova; Hui Zhang
Journal:  Anal Chem       Date:  2011-08-18       Impact factor: 6.986

8.  Markers of field cancerization: proposed clinical applications in prostate biopsies.

Authors:  Kristina A Trujillo; Anna C Jones; Jeffrey K Griffith; Marco Bisoffi
Journal:  Prostate Cancer       Date:  2012-05-14

9.  Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy.

Authors:  Sung Kyu Hong; James A Eastham; Samson W Fine
Journal:  Prostate Int       Date:  2013-12-30

10.  Anti-tumor effects of the peptide TMTP1-GG-D(KLAKLAK)(2) on highly metastatic cancers.

Authors:  Xiangyi Ma; Ling Xi; Danfeng Luo; Ronghua Liu; Shu Li; Yan Liu; Liangsheng Fan; Shuangmei Ye; Wanhua Yang; Shuhong Yang; Li Meng; Jianfeng Zhou; Shixuan Wang; Ding Ma
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.